Global Dry Eye Disease Market

Dry Eye Disease Market was valued at US$ 6.45 Bn in 2022 and is expected to growth at US$ 9.54 Bn in 2029. Global Dry Eye Disease Market size is expected to grow at a CAGR of 5.74 % through the forecast period.

Dry Eye Disease Market Overview:

Dry eye disease is also known as Keratoconjunctivitis sicca is a common condition which can be cured by treatment. It is a disease occurs when your tears aren't able to provide adequate lubrication for your eyes. Dry eyes are caused by a variety of reasons that disrupt the healthy tear film. Dry eye symptoms may be a manifestation of a systemic disease, therefore timely detection may lead to recognition of a life–threatening condition. Additionally, patients with dry eye are prone to potentially blinding infections, such as bacterial keratitis and also at an increased risk of complications following common procedures such as laser refractive surgery. This awareness has led to the development of highly effective therapies.

The report explores the Global Dry Eye Disease Market segments (Product, Type, Distribution Channel, Treatment and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2022. The report investigates the Global Dry Eye Disease Market drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Global Dry Eye Disease Market contemporary competitive scenario.To know about the Research Methodology:-Request Free Sample Report

Dry Eye Disease Market Dynamics:

Dry eye disease is caused due to lack of sufficient lubrication, moisture or tear on the surface of eyes which makes them healthy and comfortable. Whenever, a person blinks, the film of tears spreads over the eyes keeping the surface smooth which is important for good vision. The tear film is made up of 3 layers which are Oily layer, Water layer, and mucus layer. Dry eye disease is recognised by constant eye irritation, significant inflammation, and sometimes scarring of the front surface of the eye.

The Common factors responsible for Dry Eye Disease, such as aging, systemic inflammatory diseases, decrease in the supportive hormones, ocular surface diseases, or surgeries that affect the cholinergic nerves and which stimulate tear secretion. This includes the increase in dry eye disease. The awareness about the dry eye disease has led to the growth of global dry eye disease market. Many patients ignore the dry eye disease as it does not cause the any kind of weakness to any part of the body. But, the increasing awareness about the diagnosis and treatment of the disease has resulted in more patients proactively trying to cure the syndrome, driving the global dry eye syndrome market. The government support medical research by permitting researchers for treating patients of this disease more comprehensively and precisely.

The popularity of self-medication by patients, high cost and limited availability of effective therapeutics leads to the main restraint on the dry eye syndrome market at present. In addition to this, the expiration of patents on major drugs which is used in the treatment of dry eye syndrome is also a major restraint on the global dry eye syndrome market. Manufacturers in the Dry Eye Disease are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

COVID-19 Impact on Dry Eye Disease Market:

The destructive attack of the COVID-19 variants, including Delta and Omicron, has disrupted the healthcare industry with concerns which leads to the potential risk of infection in eye related diseases. Through face-to-face clinical examinations, there was a risk of increasing the Ophthalmic diseases which is related to the eye disease due to the exposure of particles in the laboratory. Amidst prevailing uncertainties, rapid advancements of AI and 5G mobile networks are likely to support online consultations, telemedicine and smartphone-based apps. The online platforms are commonly used at organizations in North America, Asia Pacific and Europe.

The potential new treatment options are introducing at the time when dry eye disease has become one of the most common diseases which causes ocular surface disorders and discomfort. A growth in the number of product approvals and new product launches are anticipated to boost up the market expansion.

As the dry eye disease is the most common disease found in most of the people after the certain age, so there rises a challenge for the people who are suffering from this disease. The people who suffer from dry eye disorder may experience the challenges such as eye infections, damage to the surface of eyes and decreased quality of life. Eye infections leads to the increase risk of an eye infection without the adequate tears in eyes. The tears protect the surface of the eye from getting infected. Damage to the surface of your eyes occurs if left untreated, severe dry eyes may lead to eye inflammation, abrasion of the corneal surface, corneal ulcers and vision loss. Dry eyes can make it difficult to perform everyday activities, such as reading which leads to the decreased quality of life.

Tyrvaya -This much anticipated nasal spray for dry eye was approved by the U.S. Food and Drug Administration in October 2021. The spray, a first of its kind treatment, stimulates tear, oil and mucin production. This nasal spray may be easier to apply than eye drops and it eliminates undesirable ocular stinging and burning sensations.

Restasis and Cequa are the medicines which was developed specifically for chronic dry eye where inflammation leads to reduced tear production.

TP-03 by Tarsus Pharmaceuticals is an eyedrop administered twice daily that helps exterminate the mites and improve symptoms. In a phase 2b clinical trial, the treatment essentially wiped out the infestation in more than 80% of patients after 43 days. This therapy could become available as early as 2022.

Dry Eye Disease Market Segment Analysis:

Based on Product, The segment anti-inflammatory drugs dominated the market with the highest market share in year 2022. Anti-inflammatory drugs are commonly used for the treatment of dry eye disease. The treatment of dry eye disease syndrome limitedly makes the use of artificial tears, ointments, and therapies which includes punctual occlusion, moisture-retaining eyewear, environmental control, and surgery. Some patients may suffer from eye irritation instead of sufficient aqueous enhancement therapies without anti-inflammatory drugs. Therefore, anti-inflammatory drugs may be considered along with aqueous enhancement therapies. Hence, it leads to the growth of anti-inflammatory drugs for the treatment of dry eye disease.The symptoms and signs of severe dry eye disease can effectively and rapidly cure by Corticosteroids which the potential anti-inflammatory drug. Corticosteroids is used to reduce the symptoms of ocular irritation and fluorescein staining of the cornea and improve filamentary keratitis. Clinical evidence acts as the growth of production of inflammatory mediators and minimizes the signs and symptoms of dry eye disease.

Based on Distribution Channel, The segment hospital pharmacies have the highest market share with xx% in year 2022. After the thorough examination by the trained medical professionals, they provide the prescription which is attributable to the high preference given to hospitals as the majority of the medications. The retail pharmacies account for the considerable dry eye syndrome market shares due to the over-the-counter availability of certain therapeutic options. The online pharmacies are expected to grow in the forecast period as it provides drugs easily and at any time convenient to the patients at the institutions.

Dry Eye Disease Market Regional Insights:

The North America region is expected to witness significant growth at a CAGR of xx% through the forecast period because of the presence of key market players associated with the dry eye syndrome treatments and huge patient population. The high occurrence of lifestyle disorders that rise the chances of contracting dry eye disease in this region is a major driver factor for the North America.

The growth and rapidly increasing number of risks of dry eye syndrome is rising due to the medicines like pain relievers, antihistamines, and antidepressants. Contact lenses may provide irritation on eye surface which affects the tear film and this leads to the need for artificial tears. The region is growing due to increasing incidence of dry eye conditions or diseases. In addition to this, many people are spending for the treatment of dry eye disease which is also leading to the growth of the market.

Asia Pacific is considered to be the second largest growing market during the forecast period. The factors likely to contribute to the market growth include the increasing incidence of dry eye disease among young people, owing to long hours spent in front of computers, the significantly rising geriatric population, the development of ophthalmic solutions, and the growing government support for eye health. Among the older population, the rising burden of aging population is the major factor for the increasing dry eye disease.

The objective of the report is to present a comprehensive analysis of the Global Dry Eye Disease Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Dry Eye Disease Market dynamic, structure by analyzing the market segments and projecting the Global Dry Eye Disease Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Dry Eye Disease Market make the report investor’s guide.

Dry Eye Disease Market Scope:Inquire before buying

Dry Eye Disease Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Dry Eye Disease Market Key Players are:

1. Novartis AG (Alcon)
2. ALLERGAN
3. Johnson & Johnson
4. Vision Care
5. Otsuka Pharmaceutical Vo. Ltd.
6. Shire
7. OASIS Medical
8. Santen Pharmaceutical Co. Ltd.
9. AFT Pharmaceuticals
10.I-Med Pharma Inc.
11.Sentiss Pharma Pvt. Ltd.
12.Scope Ophthalmics Ltd.
13.Sanofi Pasteur
14.Serum Institute
15.Bavarian Nordic
16.CSL Ltd.
17.Emergent Biosolutions, Inc.
18.F. Hoffmann-La Roche Ltd.
19.Gilead Sciences
20.Inovio Pharmaceuticals
21.Novavax, Inc.
22.SELLAS Life Sciences Group, Inc

Frequently Asked Questions:

1] What segments are covered in the Global Global Dry Eye Disease Market report?
Ans. The segments covered in the Global Dry Eye Disease Market report are based on Type and Application.

2] Which region is expected to hold the highest share in the Global Global Dry Eye Disease Market?
Ans. North America region is expected to hold the highest share in the Global Dry Eye Disease Market.

3] What is the market size of the Global Global Dry Eye Disease Market by 2029?
Ans. The market size of the Global Dry Eye Disease Market by 2029 is expected to reach US$ 9.54 Bn.

4] What is the forecast period for the Global Global Dry Eye Disease Market?
Ans. The forecast period for the Global Dry Eye Disease Market is 2023-2029.

5] What was the market size of the Global Global Dry Eye Disease Market in 2022?
Ans. The market size of the Global Dry Eye Disease Market in 2022 was valued at US$ 6.45 Bn.